New laser wavelength may offer smoother varicose vein treatment
NCT ID NCT05663359
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two laser wavelengths (1470 nm and 1940 nm) for treating varicose veins in the legs. About 280 participants will receive one of the two laser treatments and be followed for five years. The goal is to see if the newer 1940 nm wavelength works as well as the standard 1470 nm one, while possibly reducing pain and complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
endovenous laser ablation (EVLA) at 1940 nm or 1470 nm
What this could lead to
If successful, this could show that a newer laser wavelength works just as well as the standard one while causing less pain or fewer side effects.
What could go wrong
This is a relatively small, early-stage comparison study. The newer wavelength may not prove superior, and individual results can vary. Long-term benefits are not yet established.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VARICOSE VEINS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinique Pasteur
RECRUITINGToulouse, France
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact